CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Drug Discovery And Development
  • Top Drug Discovery and Development Solution Companies in Europe

Drug Discovery And Development 2022

Top 10 Drug Discovery and Development Solutions Companies in Europe - 2022

Top 10 Drug Discovery and Development Solutions Companies in Europe - 2022

The European drug discovery market is buoyant and is projected to expand by 8.3 per cent until 2030. France, Germany, and the United Kingdom are the top three European biotech hubs, representing half of all European biotechs (home to the biggest biotech centre). Additionally, the market for small molecule drug delivery in Europe is projected to reach US$ 13,381.71 million by 2027 and increase at a CAGR of 9.0 per cent during that time.

Drug discovery has progressed significantly with developing technologies, making the procedure more refined, accurate, and less time-consuming. Utilising cutting-edge technology, such as high throughput techniques, bioinformatics, and combinatorial chemistry, has increased in recent years for better drug candidate documentation. In the upcoming years, it is anticipated that the usage of artificial intelligence systems in disease diagnosis and treatment will rise significantly.

This edition of Life Sciences Review highlights the key developments in Europe's drug discovery and development space. It features a combination of thought leadership articles from Itedale Namro Redwan, CSO, CELLINK and Carlos Pedraza, PhD., Director of CNS Biology, Alkermes, with real-life stories on fostering robust partnerships and exclusive insights from CIOs and CXOs. This edition also brings you the stories of some of the most successful Small Molecules Drug Discovery and Development Solutions Providers in Europe - 2022, like ALPX and SPILLOproject. ALPX offers fully automated and remote-controlled protein-to-structure pipelines for protein crystallography and fragment and compound screening. The ALPX high-throughput services enable researchers to solve crystal structures faster, thus accelerating research in a range of fields from pharma to biotech. SPILLOproject provides a spectrum of specific services to optimise various drug discovery and development phases. It can identify the targets responsible for the therapeutic effects of a small molecule, which helps design targeted modifications to improve its affinity (Rational Drug Design).

With a plethora of solution providers in the market, this edition aims to provide you with assistance in choosing suitable small molecules drug discovery and development solution providers according to your requirements. We present to you the Top 10 Drug Discovery and Development Solutions Providers in Europe - 2022 and Top 10 Drug Discovery and Development Solutions Providers in Europe – 2022.

Let us know your thoughts

Top 10 Drug Discovery and Development Solutions Companies in Europe - 2022

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Drug Discovery and Development Solution Companies in Europe

    ★Featured Companies
    SPILLOproject
    SPILLOproject
    Read full profile →
    SPILLOproject is an Italian company that provides innovative in silico solutions for drug R&D and clinical pharmacology. It strives to fulfill its mission of improving human health and advancing research on diseases, including rare and neglected ones, by developing and using innovative technologies ... read full profile
    CN Bio
    CN Bio
    CN Bio transfers promising technologies from leading academic laboratories into the hands of pharmaceutical researchers for the development of new medicine to treat and cure disease, as well as to assist the larger academic community in understanding biology and disease pathology through the use of technologies
    Engitix Therapeutics
    Engitix Therapeutics
    Engitix Therapeutics is specialised in biotechnology research and has pioneered the world’s first human extracellular matrix-based discovery platform to aid in the discovery of targets, biomarkers, and drug profiling
    Evaxion Biotech
    Evaxion Biotech
    Evaxion Biotech is a clinical-stage AI-immunology platform company using AI technology, engineering expertise, and drug development know-how to stimulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections
    HeartBeat.bio
    HeartBeat.bio
    HeartBeat.bio is a drug discovery company dedicated to developing a high-throughput human organoid screening platform for cardiac drug discovery through self-organising cardiac organoids resembling the human physiology of a human heart chamber, allowing for cost-efficient and large-scale in vitro analysis of clinical parameters
    Iktos
    Iktos
    Iktos specialises in the development of proprietary artificial intelligence technologies and software for ligand based and structure-based de novo drug design, focusing on multi-parametric optimisation
    InSysBio
    InSysBio
    InSysBio group constitutes of Quantitative Systems Pharmacology (QSP) companies. By using QSP modelling, the business aids pharmaceutical companies in making choices during pivotal phases of medication research and development. The InSysBio team has built its own QSP infrastructure, which includes both services and software items
    Nordic Bioscience
    Nordic Bioscience
    In terms of extracellular matrix (ECM) research, Nordic Bioscience is the leading expert. The business, which has three decades of experience in biomarker discovery, assists some of the biggest pharmaceutical corporations in preclinical and clinical research
    Schrödinger
    Schrödinger
    The research activities of biopharmaceutical and industrial businesses, academic institutions, and government laboratories around the world are facilitated by Schrödinger's market leading computational platform. In a wide range of therapeutic areas, Schrödinger also has fully-owned and collaborative drug discovery initiatives
    Selexis SA
    Selexis SA
    A JSR Life Sciences Company, Selexis SA is the world leader in cell line creation. With best-in-class modular technology and highly tailored solutions, Selexis SA enables the life sciences sector to quickly find, develop, and market novel biologic drugs and vaccines
Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://drug-discovery-and-development-europe.lifesciencesreviewapac.com/vendors/top-drug-discovery-and-development-solution-companies-in-europe-2022.html